Matthew Pratt Whalen - 18 Nov 2024 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Director
Signature
/s/ Matthew Pratt Whalen
Issuer symbol
MIRA
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
3
Filing time
26 Nov 2024, 16:15:28 UTC
Previous filing
29 Aug 2024
Next filing
10 Dec 2024

No securities are beneficially owned.